ืžื•ืคืขืœ ืข"ื™
Regulation & Legal

ืื•ืชื• ืกื™ื›ื•ืŸ, ืื•ืชื ื›ืœืœื™ื: ื‘ืจื–ื™ืœ ืชืกื“ื™ืจ ืกืคืงื™ ืฉื™ืจื•ืชื™ ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื (VASPs) ื›ืžื• ื‘ืจื•ืงืจืื–'ื™ื ืžืกื•ืจืชื™ื™ื ืฉืœ ื ื™ื™ืจื•ืช ืขืจืš

ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืฉืœ ื‘ืจื–ื™ืœ ื›ืœืœ ื›ืขืช ืืช ืกืคืงื™ ืฉื™ืจื•ืชื™ ื”ื ื›ืกื™ื ื”ื•ื•ื™ืจื˜ื•ืืœื™ื™ื (VASPs) ืชื—ืช ืกื™ื•ื•ื’ Type 3, ืขื ืื•ืชืŸ ื“ืจื™ืฉื•ืช ื›ืžื• ื—ื‘ืจื•ืช ืชื™ื•ื•ืš ื•ื”ืคืฆืช ื ื™ื™ืจื•ืช ืขืจืš. ื‘ื ื•ืกืฃ, ื”ื›ืœืœื™ื ืฉืื•ืฉืจื• ืžื—ืจื™ื’ื™ื ืืช ื”โ€‘VASPs ืžืงื‘ืœืช ืกื™ื•ื•ื’ Segment 5, ืžืฉื˜ืจ ืžืคื•ืฉื˜ ืœืžื•ืกื“ื•ืช ื‘ืขืœื™ ืคืจื•ืคื™ืœ ืกื™ื›ื•ืŸ ื ืžื•ืš.

ื ื›ืชื‘ ืข"ื™
ืฉืชืฃ
ืื•ืชื• ืกื™ื›ื•ืŸ, ืื•ืชื ื›ืœืœื™ื: ื‘ืจื–ื™ืœ ืชืกื“ื™ืจ ืกืคืงื™ ืฉื™ืจื•ืชื™ ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื (VASPs) ื›ืžื• ื‘ืจื•ืงืจืื–'ื™ื ืžืกื•ืจืชื™ื™ื ืฉืœ ื ื™ื™ืจื•ืช ืขืจืš

Key Takeaways

  • ื‘ืจื–ื™ืœ ืคืจืกืžื” ืืช ื”ื—ืœื˜ื” 580/2026 ืฉืžืงื‘ืฆืช ืืช ื”โ€‘VASPs ืœโ€‘Type 3, ื‘ื”ืชืื ืœื›ืœืœื™ ืชื™ื•ื•ืš, ื›ืืฉืจ ืขืœื•ื™ื•ืช ื”ืฆื™ื•ืช ืžื–ื ืงื•ืช.
  • ื—ื‘ืจื•ืช ืงืจื™ืคื˜ื• ื™ืขืžื“ื• ื‘ืคื ื™ ื›ืœืœื™ ื”ื•ืŸ ื•ืกื™ื›ื•ืŸ ืžื—ืžื™ืจื™ื ื”ื—ืœ ืžโ€‘1 ื‘ื™ื ื•ืืจ 2027, ืžื” ืฉื™ื“ื—ื•ืฃ ื‘ื”ืžืฉืš ืœืื™ื—ื•ื“ ื‘ืขื ืฃ.
  • ื”โ€‘VASPs ื™ื™ื›ื ืกื• ืœโ€‘Segment 4 ืขื“ 30 ื‘ื™ื•ื ื™ 2028, ื™ืื‘ื“ื• ื”ื˜ื‘ื•ืช ืฉืœ ืกื™ื›ื•ืŸ ื ืžื•ืš ื›ืืฉืจ ื”ื‘ื ืง ื™ื’ื‘ื™ืจ ื‘ื”ืžืฉืš ืืช ื”ืžืขืงื‘.

ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืฉืœ ื‘ืจื–ื™ืœ ืžืฉื•ื•ื” ืืช ื™ื—ืก ื”ืฆื™ื•ืช ื‘ื™ืŸ VASPs ืœื‘ื™ืŸ ื‘ืจื•ืงืจืื–โ€™ื™ื ืœื ื™ื™ืจื•ืช ืขืจืš

ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืฉืœ ื‘ืจื–ื™ืœ ืžื”ื“ืง ืืช ื”ื›ืœืœื™ื ืฉื—ื‘ืจื•ืช ืงืจื™ืคื˜ื• ื•ืกืคืงื™ ืฉื™ืจื•ืชื™ ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื (VASPs) ื—ื™ื™ื‘ื™ื ืœืคืขื•ืœ ืœืคื™ื”ื ื›ื“ื™ ืœืคืขื•ืœ ื‘ืžื“ื™ื ื”.

ื‘ื™ื•ื ืจื‘ื™ืขื™ ื”ื‘ื ืง ืคืจืกื ืืช ื”ื—ืœื˜ื” ืžืกโ€™ 580/2026, ื”ืžืชืงื ืช ืืช ื”ื—ืœื˜ื•ืช 436/2024 ื•โ€‘201/2022, ื›ื“ื™ ืœืกื•ื•ื’ ื—ื‘ืจื•ืช ื”ืžืกืคืงื•ืช ืฉื™ืจื•ืชื™ ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื ื•ืงื•ื ื’ืœื•ืžืจื˜ื™ื ื”ืžื•ื ื”ื’ื™ื ืขืœ ื™ื“ื™ ื—ื‘ืจื•ืช ืืœื• ื›โ€‘Type 3.

Infographic on Brazil's new VASP rules

ืœืคื ื™ ื›ืŸ, ืกื™ื•ื•ื’ Type 3 ื›ืœืœ ื—ื‘ืจื•ืช ืชื™ื•ื•ืš ื‘ื ื™ื™ืจื•ืช ืขืจืš, ื—ื‘ืจื•ืช ื”ืคืฆื” ืฉืœ ื ื™ื™ืจื•ืช ืขืจืš ื•ื—ื‘ืจื•ืช ืชื™ื•ื•ืš ื‘ืžื˜โ€ื—; ื›ืขืช ืžื—ืœืงื” ื–ื• ื›ื•ืœืœืช ื’ื VASPs, ื•ืžื—ื™ืœื” ืืช ืื•ืชืŸ ื“ืจื™ืฉื•ืช ืขืœ ืžื•ืกื“ื•ืช ืืœื”.

ืžืฉืžืขื•ืช ื”ื“ื‘ืจ ื”ื™ื ืฉืžโ€‘1 ื‘ื™ื ื•ืืจ 2027 ืžื•ืกื“ื•ืช ืืœื” ื™ื”ื™ื• ื›ืคื•ืคื™ื โ€œืœืžืขืจืš ืฉืœ ื“ืจื™ืฉื•ืช ืคืจื•ื“ื ืฆื™ืืœื™ื•ืช, ืœืจื‘ื•ืช ื›ืœืœื™ ื ื™ื”ื•ืœ ืกื™ื›ื•ื ื™ื, ื“ืจื™ืฉื•ืช ื”ื•ืŸ ื•ืžื“ื™ื ื™ื•ืช ื’ื™ืœื•ื™ ืžื™ื“ืข.โ€

ืœืคื™ ื”ื•ื“ืขื” ืฉืคืจืกื ื”ื‘ื ืง ื”ืžืจื›ื–ื™, ืกื™ื•ื•ื’ Type 3 ื–ื” โ€œืžืงืจื‘ ืืช ื”ื˜ื™ืคื•ืœ ื”ืจื’ื•ืœื˜ื•ืจื™ ื‘ื—ื‘ืจื•ืช ืืœื” ืœื–ื” ื”ืžืื•ืžืฅ ืขื‘ื•ืจ ื—ื‘ืจื•ืช ืชื™ื•ื•ืš ื•ื”ืคืฆืช ื ื™ื™ืจื•ืช ืขืจืš, ื•ืžืฉืงืฃ ื“ืžื™ื•ืŸ ืชืคืงื•ื“ื™ ื‘ื™ืŸ ื”ืžื•ื“ืœื™ื ื”ืขืกืงื™ื™ื ืฉืœื”ืŸ,โ€ ื‘ื”ืชืื ืœื”ืžืœืฆื•ืช ื‘ื™ื ืœืื•ืžื™ื•ืช ืขืœ ื‘ืกื™ืก ืขืงืจื•ื ื•ืช โ€œืื•ืชื” ืคืขื™ืœื•ืช, ืื•ืชื• ืกื™ื›ื•ืŸ, ืื•ืชื” ืจื’ื•ืœืฆื™ื”โ€.

ื‘ื ื•ืกืฃ, ื”โ€‘VASPs ื™ื™ื›ืœืœื• ื‘โ€‘Segment 4 ืœืœื ืงืฉืจ ืœื’ื•ื“ืœ ืขื“ 30 ื‘ื™ื•ื ื™ 2028. Segment 4 ืžืงื‘ืฅ ืžื•ืกื“ื•ืช ืฉื’ื•ื“ืœื ืงื˜ืŸ ืžโ€‘0.1% (ืขืฉื™ืจื™ืช ื”ืื—ื•ื–) ืžื”ืชื•ืฆืจ ื”ืžืงื•ืžื™ ื”ื’ื•ืœืžื™ (GDP) ืฉืœ ื‘ืจื–ื™ืœ.

ื‘ืื•ืชื” ืžื™ื“ื”, ื”ื”ื—ืœื˜ื” ืžื•ื ืขืช ืžโ€‘VASPs ืœืงื‘ืœ ื”ื˜ื‘ื•ืช Segment 5, ื”ื›ื•ืœืœื•ืช ืžืฉื˜ืจ ืฆื™ื•ืช ืžืคื•ืฉื˜ ืœืžื•ืกื“ื•ืช ื‘ืขืœื™ ืคืจื•ืคื™ืœ ืกื™ื›ื•ืŸ ื ืžื•ืš.

โ€œื‘ืืžืฆืขื•ืช ื™ื•ื–ืžื” ื–ื• ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืžืชืงื“ื ื‘ื‘ื ื™ื™ืช ืกื‘ื™ื‘ืช ืจื’ื•ืœืฆื™ื” ื‘ื˜ื•ื—ื” ื•ืžื™ื“ืชื™ืช ืœืคื™ืชื•ื— ืคืขื™ืœื•ื™ื•ืช ืขื ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื ื‘ื‘ืจื–ื™ืœ, ืชื•ืš ื”ืชืืžื” ืœืฉื™ื˜ื•ืช ื”ืขื‘ื•ื“ื” ื”ืžื•ืžืœืฆื•ืช ื”ื‘ื™ื ืœืื•ืžื™ื•ืช ื•ืœื”ืชืคืชื—ื•ืช ื”ืžืขืจื›ืช ื”ืคื™ื ื ืกื™ืช,โ€ ืกื™ื›ื ื”ื‘ื ืง.

Valor Econรณmico ื”ื“ื’ื™ืฉ ื›ื™ ื”ืžื”ืœืš ืœื ื”ืชืงื‘ืœ ื”ื™ื˜ื‘ ืืฆืœ ืžื ื”ืœื™ื ื‘ืชืขืฉื™ื™ืช ื”ืงืจื™ืคื˜ื•, ื”ืฆื•ืคื™ื ื”ืžืฉืš ืื™ื—ื•ื“ ื‘ืžืขืจื›ืช ื”ืืงื•ืœื•ื’ื™ืช.

โ€œื–ื” ืœื ื ืจืื” ื”ื’ื™ื•ื ื™ ื‘ืžื™ื•ื—ื“ ื‘ืžื•ื ื—ื™ื ืฉืœ โ€˜ืื•ืชื• ืกื™ื›ื•ืŸ, ืื•ืชื” ืจื’ื•ืœืฆื™ื”โ€™. ื”ื“ื‘ืจ ื”ื—ื™ื•ื‘ื™ ื”ื•ื ืฉื–ื” ื ื›ื ืก ืœืชื•ืงืฃ ืจืง ื‘โ€‘2027, ื›ืš ืฉื™ืฉ ืœื ื• ื–ืžืŸ ืœื”ืกืชื’ืœ,โ€ ื”ืขื™ืจ ืžื ื”ืœ ืœื ืžื–ื•ื”ื”.

ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืฉืœ ื‘ืจื–ื™ืœ ื™ืงื“ื ืืช ื”ืจื’ื•ืœืฆื™ื” ื”ืžื•ืกื“ื™ืช ืฉืœ VASP ืขื“ 2027

ื”ื‘ื ืง ื”ืžืจื›ื–ื™ ืฉืœ ื‘ืจื–ื™ืœ ื™ืงื“ื ืืช ื”ืจื’ื•ืœืฆื™ื” ื”ืžื•ืกื“ื™ืช ืฉืœ VASP ืขื“ 2027

ื’ืœื• ื›ื™ืฆื“ ื‘ืจื–ื™ืœ ืžืงื™ืžื” ืžืกื’ืจืช ืจื’ื•ืœื˜ื•ืจื™ืช ืขื‘ื•ืจ ืกืคืงื™ ืฉื™ืจื•ืชื™ ื ื›ืกื™ื ื•ื™ืจื˜ื•ืืœื™ื™ื (VASPs) ืžื•ืกื“ื™ื™ื ื›ื“ื™ ืœืชืžื•ืš ื‘ื ื•ืฃ ื”ืงืจื™ืคื˜ื• ื”ืžืชืคืชื—. read more.

ืžืืžืจ ื–ื” ืชื•ืจื’ื ืžืื ื’ืœื™ืช ื‘ืืžืฆืขื•ืช ื‘ื™ื ื” ืžืœืื›ื•ืชื™ืช. ื”ื’ืจืกื” ื”ืžืงื•ืจื™ืช ื‘ืื ื’ืœื™ืช ื”ื™ื ื”ืžืงื•ืจ ื”ืงื•ื‘ืข; ืชืจื’ื•ืžื™ื ืื•ื˜ื•ืžื˜ื™ื™ื ืขืฉื•ื™ื™ื ืœื”ื›ื™ืœ ืื™-ื“ื™ื•ืงื™ื, ื‘ืžื™ื•ื—ื“ ื‘ืžื•ื ื—ื™ื ืžืฉืคื˜ื™ื™ื ื•ืจื’ื•ืœื˜ื•ืจื™ื™ื.

ืชื’ื™ื•ืช ื‘ื›ืชื‘ื” ื–ื•